Israel Englander’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-5,676
| Closed | -$2.62M | – | 6193 |
|
|
2026
Q1 | $2.73M | Sell |
5,676
-46,315
| -89% | -$23.7M | ﹤0.01% | 3570 |
|
|
2025
Q4 | $29.2M | Sell |
51,991
-64,620
| -55% | -$36.7M | 0.01% | 1211 |
|
|
2025
Q3 | $60M | Sell |
116,611
-228,319
| -66% | -$99.7M | 0.03% | 740 |
|
|
2025
Q2 | $108M | Buy |
344,930
+252,169
| +272% | +$75.7M | 0.05% | 356 |
|
|
2025
Q1 | $28.3M | Sell |
92,761
-21,004
| -18% | -$7.07M | 0.02% | 1202 |
|
|
2024
Q4 | $37.8M | Buy |
113,765
+690
| +0.6% | +$234K | 0.02% | 980 |
|
|
2024
Q3 | $37.7M | Buy |
113,075
+3,272
| +3% | +$1.24M | 0.02% | 1019 |
|
|
2024
Q2 | $45.2M | Sell |
109,803
-25,629
| -19% | -$10.1M | 0.02% | 872 |
|
|
2024
Q1 | $54.7M | Buy |
135,432
+66,736
| +97% | +$23.5M | 0.02% | 771 |
|
|
2023
Q4 | $21.1M | Sell |
68,696
-1,271
| -2% | -$343K | 0.01% | 1497 |
|
|
2023
Q3 | $16.9M | Sell |
69,967
-358,810
| -84% | -$91.8M | 0.01% | 1561 |
|
|
2023
Q2 | $103M | Buy |
428,777
+21,234
| +5% | +$4.41M | 0.05% | 354 |
|
|
2023
Q1 | $76.6M | Sell |
407,543
-43,395
| -10% | -$8.98M | 0.04% | 454 |
|
|
2022
Q4 | $95.8M | Buy |
450,938
+243,001
| +117% | +$48.5M | 0.05% | 398 |
|
|
2022
Q3 | $32.7M | Buy |
207,937
+11,850
| +6% | +$1.89M | 0.02% | 954 |
|
|
2022
Q2 | $29.3M | Buy |
196,087
+24,566
| +14% | +$3.56M | 0.02% | 975 |
|
|
2022
Q1 | $28.1M | Buy |
171,521
+121,787
| +245% | +$20.1M | 0.01% | 1075 |
|
|
2021
Q4 | $10.8M | Sell |
49,734
-3,577
| -7% | -$749K | 0.01% | 2072 |
|
|
2021
Q3 | $10.1M | Buy |
53,311
+41,979
| +370% | +$7.66M | 0.01% | 2033 |
|
|
2021
Q2 | $2M | Buy |
+11,332
| New | +$1.96M | ﹤0.01% | 3964 |
|
|
2021
Q1 | – | Sell |
-4,357
| Closed | -$606K | – | 6280 |
|
|
2020
Q4 | $606K | Sell |
4,357
-93,550
| -96% | -$11.8M | ﹤0.01% | 4056 |
|
|
2020
Q3 | $10.9K | Buy |
97,907
+74,082
| +311% | +$8.57M | 0.01% | 1176 |
|
|
2020
Q2 | $2.22M | Buy |
+23,825
| New | +$2.03M | ﹤0.01% | 2449 |
|
|
2020
Q1 | – | Sell |
-3,018
| Closed | -$254K | – | 4238 |
|
|
2019
Q4 | $254K | Sell |
3,018
-84,358
| -97% | -$6.53M | ﹤0.01% | 3751 |
|
|
2019
Q3 | $7.34M | Buy |
+87,376
| New | +$6.6M | 0.01% | 1506 |
|
|
2019
Q2 | – | Sell |
-32,933
| Closed | -$1.9M | – | 4307 |
|
|
2019
Q1 | $1.94M | Sell |
32,933
-236,693
| -88% | -$14.1M | ﹤0.01% | 2429 |
|
|
2018
Q4 | $14.3M | Sell |
269,626
-109,063
| -29% | -$5.99M | 0.02% | 906 |
|
|
2018
Q3 | $22.7M | Buy |
378,689
+290,038
| +327% | +$15.9M | 0.03% | 784 |
|
|
2018
Q2 | $3.81M | Buy |
+88,651
| New | +$3.58M | 0.01% | 1978 |
|
|
2018
Q1 | – | Sell |
-13,854
| Closed | -$502K | – | 3905 |
|
|
2017
Q4 | $502K | Sell |
13,854
-81,772
| -86% | -$2.87M | ﹤0.01% | 3092 |
|
|
2017
Q3 | $3.05M | Buy |
+95,626
| New | +$2.92M | ﹤0.01% | 1950 |
|
|
2017
Q2 | – | Sell |
-31,257
| Closed | -$933K | – | 3691 |
|
|
2017
Q1 | $933K | Sell |
31,257
-162,834
| -84% | -$5.26M | ﹤0.01% | 2439 |
|
|
2016
Q4 | $7M | Buy |
194,091
+94,321
| +95% | +$3.14M | 0.01% | 1117 |
|
|
2016
Q3 | $2.98M | Buy |
+99,770
| New | +$2.91M | 0.01% | 1667 |
|
Other funds holding MEDP
WA
Israel Englander's MEDP Position: Q2 2026 in Review
Israel Englander sold out of Medpace (MEDP) in Q2 2026, closing a stake of 5,676 shares — an estimated $2.62M sold.
Israel Englander first reported a position in MEDP in Q3 2016 and held it in 34 quarters. The position peaked at $108M in Q2 2025. 693 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.
- Israel Englander reported no remaining Medpace position as of Q2 2026 after selling out during the quarter.
- Israel Englander sold 5,676 Medpace shares in Q2 2026, an estimated $2.62M.
- Israel Englander first reported a position in Medpace in Q3 2016 and held it in 34 quarters.
- Israel Englander's Medpace position peaked at $108M in Q2 2025.
- 693 funds tracked by Wall St. Rank held Medpace as of Q2 2026.
Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.